Medicus Pharma (MDCX) Earnings
Medicus Pharma reported on November 6, 2026: EPS of -11.64 against -8.50 expected, a miss.
Summary
In the quarter ended September 2026, Medicus Pharma had revenue of —, and diluted EPS of -11.64.
Report dates
| Report | Date | Time | EPS estimate | EPS reported | Result |
|---|---|---|---|---|---|
| Last | Fri Nov 6, 2026 | — | -8.50 | -11.64 | Missed |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Also reporting the week of November 2
| Company | Date | Time |
|---|---|---|
| Apple Inc AAPL | Mon Nov 2 | Reported |
| Advanced Micro Devices Inc AMD | Tue Nov 3 | Reported |
| Palantir Technologies Inc. PLTR | Mon Nov 2 | Reported |
| Toyota Motor Corporation ADR TM | Wed Nov 4 | Reported |
| Amgen Inc AMGN | Tue Nov 3 | Reported |
| Arista Networks ANET | Tue Nov 3 | Reported |
| McDonald’s Corporation MCD | Wed Nov 4 | Reported |
| Shopify Inc SHOP | Tue Nov 3 | Reported |
Quarterly results
The last 11 quarters from Medicus Pharma's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | — | — | -11.64 | — | — | 2026-11-06 |
| Jun 30, 2026 | — | — | -10.50 | — | — | 2026-08-12 |
| Mar 31, 2026 | — | — | -15.50 | — | — | 2026-05-14 |
| Dec 31, 2025 | — | — | — | — | — | 2026-03-25 |
| Sep 30, 2025 | — | — | -56.18 | — | — | 2025-11-14 |
| Jun 30, 2025 | — | — | -21.50 | — | — | 2025-08-11 |
| Mar 31, 2025 | — | — | -21.00 | — | — | 2025-05-12 |
| Dec 31, 2024 | — | — | — | — | — | 2025-03-28 |
| Sep 30, 2024 | — | — | -12.00 | — | — | 2025-11-14 |
| Jun 30, 2024 | — | — | -22.00 | — | — | 2025-08-11 |
| Mar 31, 2024 | — | — | -10.50 | — | — | 2025-05-12 |
Questions about Medicus Pharma
Did Medicus Pharma beat earnings estimates?
In its report on November 6, 2026, Medicus Pharma missed the EPS estimate: -11.64 reported against -8.50 expected.
How did Medicus Pharma do last quarter?
In the quarter ended September 2026, Medicus Pharma had revenue of —, and diluted EPS of -11.64.
From Medicus Pharma's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.